Chronic myelomonocytic leukemia (CMML) is a rare hematological disorder characterized by variable risk of evolution to acute myeloid leukemia; to date, allogeneic stem cell transplantation is the only curative treatment. We report a case of choroidal involvement in a woman affected by CMML and presenting only with visual impairment. The patient was initially evaluated for an intensive therapeutic approach, but after biopsy the ocular lesion spontaneously regressed. Thus a “watch and wait” strategy was preferred. One year and a half after initial diagnosis, the patient is alive, with stable hematological disease and without any ocular involvement. Therefore, a close, not invasive follow up could be useful to tailor treatment for patients affected by single ocular lesions in CMML.

Spontaneous remission of choroidal involvement by chronic myelomonocytic leukemia: a case report / Diral, E.; Catalano, G.; Cicinelli, M. V.; Distefano, A.; Mastaglio, S.; Vago, L.; Lupo Stanghellini, M. T.; Bernardi, M.; Ponzoni, M.; Ciceri, F.; Carrabba, M. G.. - In: FRONTIERS IN ONCOLOGY. - ISSN 2234-943X. - 14:(2024). [10.3389/fonc.2024.1399894]

Spontaneous remission of choroidal involvement by chronic myelomonocytic leukemia: a case report

Cicinelli M. V.;Distefano A.;Vago L.;Ponzoni M.;Ciceri F.
Penultimo
;
2024-01-01

Abstract

Chronic myelomonocytic leukemia (CMML) is a rare hematological disorder characterized by variable risk of evolution to acute myeloid leukemia; to date, allogeneic stem cell transplantation is the only curative treatment. We report a case of choroidal involvement in a woman affected by CMML and presenting only with visual impairment. The patient was initially evaluated for an intensive therapeutic approach, but after biopsy the ocular lesion spontaneously regressed. Thus a “watch and wait” strategy was preferred. One year and a half after initial diagnosis, the patient is alive, with stable hematological disease and without any ocular involvement. Therefore, a close, not invasive follow up could be useful to tailor treatment for patients affected by single ocular lesions in CMML.
2024
Inglese
Frontiers Media SA
14
1399894
3
Pubblicato
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1399894/full
Esperti non anonimi
Internazionale
Goal 3: Good health and well-being
chronic myelomonocytic leukemia
multimodal imaging analysis
ocular involvement
personalized medicine
watch and wait approach
No
Spontaneous remission of choroidal involvement by chronic myelomonocytic leukemia: a case report / Diral, E.; Catalano, G.; Cicinelli, M. V.; Distefano, A.; Mastaglio, S.; Vago, L.; Lupo Stanghellini, M. T.; Bernardi, M.; Ponzoni, M.; Ciceri, F.; Carrabba, M. G.. - In: FRONTIERS IN ONCOLOGY. - ISSN 2234-943X. - 14:(2024). [10.3389/fonc.2024.1399894]
open
11
info:eu-repo/semantics/article
262
Diral, E.; Catalano, G.; Cicinelli, M. V.; Distefano, A.; Mastaglio, S.; Vago, L.; Lupo Stanghellini, M. T.; Bernardi, M.; Ponzoni, M.; Ciceri, F.; Ca...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
File in questo prodotto:
File Dimensione Formato  
fonc-14-1399894.pdf

accesso aperto

Tipologia: PDF editoriale (versione pubblicata dall'editore)
Licenza: Creative commons
Dimensione 401.12 kB
Formato Adobe PDF
401.12 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/164919
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact